Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …
The government is to work with doctors, nurses, cancer charities and others to draw up a new Cancer Reform Strategy …
The first awards have been made in the Wellcome Trust's £91 million, five-year plan for novel drugs to tackle obesity, …
Two major pharma companies could be set to follow Pfizer in using a single supply chain distributor of their medicines …
The government says GPs could help save the health service £85 million a year by switching patients on branded statins …
The head of NICE's drug appraisal process has said the institute's new fast-track system is not a "soft option" through …
AstraZeneca and Bristol-Myers-Squibb are collaborating on the development of two new drugs for the treatment of type II diabetes.Saxagliptin, a …
A cutting-edge stem cell clinical trial for chronic stroke patients looks set to go ahead later this year.Biotech company ReNeuron, …
Clinicians are being urged to use new software developed to help the NHS prevent unnecessary admission to hospital.Thousands of patients …
The quest to convert inventions (i.e. promising ideas) into innovations (i.e. commercial products) is a central and vital feature of …
Novartis is preparing to set a new record for the pharmaceutical industry by launching eight new products in the next …
Eisai has applied to the High Court for permission to request a legal hearing into NICE's decision to ban anti-dementia …
With 2007 predicted to be the warmest year on record, the pressure is on for companies worldwide to 'go green'. …
Analysts are predicting that 2007 will be a strong year for European biotech, which is forecast to outstrip the growth …
Two European biotech companies have received a grant of two million euros to jointly develop a new class of anti-angiogenesis …
Swiss-based Roche has forged a partnership that could lead to the development of new treatments for schizophrenia, cognitive disorders, Parkinson's …
GlaxoSmithKline has bought US-based biotech company, Praecis, to further boost its novel cancer pipeline.Its acquisition of Praecis Pharmaceuticals follows the …
Swiss-based biotech company Speedel has axed its current phase III trial of SPP301 in diabetic kidney disease because of patient …
Roche and Genentech's Tarceva has received a positive EU opinion for the treatment of metastatic pancreatic cancer and approval is …
Lymington New Forest Hospital has become the first NHS facility in England to be run entirely by the private sector.Colchester-based …